Aquinnah Pharmaceuticals, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Aquinnah Pharmaceuticals, Inc.
Quantité totale PI 14
Rang # Quantité totale PI 110 873
Note d'activité PI 1,6/5.0    7
Rang # Activité PI 135 623

Brevets

Marques

3 0
1 0
10 0
0
 
Dernier brevet 2025 - Compounds for treatment of neuro...
Premier brevet 2012 - Identification of compounds that...

Derniers inventions, produits et services

2024 Invention Compounds for treatment of neurodegenerative diseases. Herein, compounds, compositions and method...
Invention Inhibitors of tdp-43 and tau aggregation. Herein, compounds, compositions and methods for modulat...
2022 Invention Compounds, compositions and methods of use. Herein, compounds, compositions and methods for modu...
Invention Compounds, compositions and methods of use. Herein, compounds, compositions and methods for modul...
2017 Invention Substituted cyclohexyl carboxamide derivatives as inhibitors of stress granules and tdp-43 inclus...
2016 Invention Nucleic acid based tia-1 inhibitors. The disclosure provides, e.g., nucleic acid based inhibitor...
Invention Compounds, compositions and methods of use against stress granules. Herein, compounds, compositi...
Invention Nucleic acid based tia-1 inhibitors. The disclosure provides, e.g., nucleic acid based inhibitors...
Invention Compounds, compositions and methods of use against stress granules. Herein, compounds, compositio...
Invention Identification of compounds that disperse tdp-43 inclusions. Herein, compounds and compositions ...
2015 Invention Compounds, compositions and methods of use. Herein, compounds of Formula (I) or (II), composition...
Invention Sulfonamide derivatives, compositions and methods of use in the treatment of neurodegenerative di...
2012 Invention Identification of compounds that disperse tdp-43 inclusions. Herein, methods of modulating inclus...